http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014014389-A3
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_59cb995a289b3e4dced00910a5ad3d45 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a723ff85f5b1cd7468c68d34c1d7c426 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3e00658d2c1c8483e0b2866b159c6ee8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6ff15ccc126b20fd06e4a06357f330da |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0063 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4164 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-155 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-38 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-21 |
| filingDate | 2013-07-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0ddc5c68b8b776262a779020437dbed5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_54897be065ec4c0beccbaef28f4218d4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a93cc80b5d2a8df2f2e59021e1f42086 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_45b3315f287c5238b1a2eba1bf2f390b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_669c7539b0313ec83b5ffbf0fd409847 |
| publicationDate | 2014-03-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | WO-2014014389-A3 |
| titleOfInvention | Composition in gel form for the prophylaxis and treatment of periodontal diseases |
| abstract | The invention relates to medicine, specifically to dentistry, and concerns medicinal agents for the prophylaxis and treatment of infectious and inflammatory periodontal diseases, particularly medicinal agents for the prophylaxis and treatment of periodontosis. Essence of the invention: A pharmaceutical composition in the form of a gel for the prophylaxis and treatment of periodontal diseases, containing metronidazole benzoate and chlorhexidine gluconate as the active agent, carbomer and hydroxypropyl methylcellulose as the gelling agent, menthol as the flavoring agent, a sweetener, EDTA disodium salt as an auxiliary component, and a base for lending consistency. The pharmaceutical composition additionally contains, as an active agent, components chosen from the following group: a recombinant alpha, beta or gamma interferon, lysine, proline, choline salicylate. The sweetener is saccharin or sorbitol. The pharmaceutical composition may additionally contain, as an auxiliary component, triethanolamine in the amount of 0.5-5.0 mass percent. The base for lending consistency is in the form of components chosen from the following group: glycerin, polyethylene glycol 400, polyethylene glycol 4000, propylene glycol, glycerin, and purified water. |
| priorityDate | 2012-07-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 106.